Monoject Insulin Syringe Coupons & Savings Card – Discount Prices from $4.88

When using Monoject insulin syringes, it's important to be aware of certain safety concerns to ensure proper insulin administration and avoid potential health risks.

Compatibility Issues with Needleless IV Connectors

Certain Monoject U-100 1 mL Insulin Syringes with Luer-Lock tips have been found to be incompatible with needleless intravenous (IV) connectors. This incompatibility can prevent the full dose of insulin from being delivered when administered through an IV push using a needleless connector. As a result, patients may not receive the intended amount of insulin, leading to serious health consequences such as hyperglycemia (high blood sugar), hypoglycemia (low blood sugar), diabetic ketoacidosis, or even death. In response to this issue, a recall was initiated to remove the affected syringes from use. Users are advised not to use these specific syringes for IV insulin administration with needleless connectors.

Incompatibility with Syringe and PCA Pumps

Monoject syringes have also been reported to have dimensional differences compared to previous models, leading to compatibility issues when used with syringe pumps and patient-controlled analgesia (PCA) pumps. These differences can result in the pump failing to recognize the syringe, leading to inaccurate dosing, delays in therapy, or delays in occlusion alarms. Such issues can cause patients to receive either too much or too little medication, posing significant health risks. Healthcare providers and patients are advised not to use Monoject syringes with these types of pumps until further evaluations are completed.

General Safety Precautions

To minimize risks associated with insulin syringe use:

• Do Not Share Syringes: Each syringe is intended for single-patient use to prevent the transmission of infections.

• Proper Disposal: After use, dispose of syringes in designated sharps containers to prevent needlestick injuries and environmental contamination.

• Storage: Store syringes in a clean, dry place away from direct sunlight and extreme temperatures to maintain their integrity.

By adhering to these safety guidelines and being aware of potential compatibility issues, users can help ensure the effective and safe administration of insulin.

Monoject insulin syringes are designed for subcutaneous insulin administration and are compatible with U-100 insulin, the standard concentration used by most patients. These syringes come with permanently attached needles, reducing dead space and minimizing insulin waste. They are available in various sizes, including 3/10 mL, 1/2 mL, and 1 mL capacities, with needle gauges of 29G or 30G and lengths of 1/2 inch or 5/16 inch, allowing users to select the most comfortable and appropriate option for their needs.

It's important to note that certain Monoject syringes, specifically the Monoject U-100 1 mL Insulin Syringe Luer-Lock with Tip Cap Soft Pack, have been recalled due to incompatibility with needleless IV connectors. Using these syringes for intravenous insulin administration through a needleless connector may result in incomplete insulin delivery, potentially leading to serious health consequences such as hyperglycemia, hypoglycemia, diabetic ketoacidosis, or even death. Therefore, these syringes should not be used for intravenous insulin administration with needleless connectors.

For patients using insulin pens, Monoject offers safety pen needles that are compatible with all major brands of pen injectors. These pen needles feature shorter needle lengths and a 32G option to enhance comfort during injections. The safety mechanism includes a manual push tab for one-handed activation and a safety guard covering both ends of the needle to help prevent needlestick injuries.

When selecting insulin delivery devices, it's crucial to choose products that are compatible with your specific insulin type and administration method. Always consult with your healthcare provider to ensure you're using the appropriate equipment for your insulin therapy.